77 related articles for article (PubMed ID: 2958873)
1. T cell suppression as an obstacle to immunologically-mediated tumor regression: elimination of suppression results in regression.
North RJ; Awwad M
Prog Clin Biol Res; 1987; 244():345-58. PubMed ID: 2958873
[No Abstract] [Full Text] [Related]
2. Evidence for an inducer-suppressor T cell in the regulation of DTH to alloantigens.
Molendijk A; van Gurp RJ; Benner R
Transplant Proc; 1987 Oct; 19(5):4261-4. PubMed ID: 2960054
[No Abstract] [Full Text] [Related]
3. Suppressor T cells induced by UV-B irradiation suppress DTH to alloantigens.
Molendijk A; van Gurp RJ; Benner R
Transplant Proc; 1987 Oct; 19(5):4258-60. PubMed ID: 2960053
[No Abstract] [Full Text] [Related]
4. Contrasuppression, tolerance, and tumor immunity.
Green DR; Friedman A; Ptak W; McGhee J; Flood PM
Prog Clin Biol Res; 1989; 288():245-58. PubMed ID: 2566175
[No Abstract] [Full Text] [Related]
5. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
Kumar RK; Lykke AW; Penny R
J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
Chow KP; Battisto JR
J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
[TBL] [Abstract][Full Text] [Related]
9. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
Shu S; Chou T; Rosenberg SA
Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms in tumor immunity: introduction and summary.
Rich RR
Fed Proc; 1981 Jan; 40(1):36-8. PubMed ID: 6450064
[No Abstract] [Full Text] [Related]
11. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
Miura T; Maekawa T; Kurashige S; Mitsuhashi S
Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
[TBL] [Abstract][Full Text] [Related]
12. RCS tumor-host interactions: tumor growth dependence on L3T4+ T cells and its regulation by suppressor cells.
Ohnishi K; Bonavida B
Prog Clin Biol Res; 1987; 244():359-68. PubMed ID: 2958874
[No Abstract] [Full Text] [Related]
13. Regulatory T cells, tumour immunity and immunotherapy.
Zou W
Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261
[TBL] [Abstract][Full Text] [Related]
14. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity.
Matriano JA; Socarras S; Streilein JW
J Immunol; 1994 Aug; 153(4):1505-14. PubMed ID: 7913940
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific T contrasuppressor factor in cell-mediated immunity: interactions leading to eradication of the tolerant state.
Ptak W; Bereta M; Ptak M; Gershon RK; Green DR
J Immunol; 1984 Sep; 133(3):1124-30. PubMed ID: 6205065
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
19. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
20. Adoptive immunotherapy of newly induced murine sarcomas.
Shu SY; Rosenberg SA
Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
